Feb 14, 2008 by Brian Orelli, PhDA Lovey-Dovey DuoA peek at two drug companies that hooked up to market a hot product.
Feb 14, 2008 by Brian Orelli, PhDDrug Developer Displays Its GoodsDyax strikes a deal with Sanofi-Aventis.
Feb 13, 2008 by Brian Orelli, PhDSchering-Plough Has No Love for the MediaThe drug company pushes on after the Enhance trials.
Feb 8, 2008 by Brian Orelli, PhDMerck in Lukewarm WaterThe pharmaceutical's settlement ends a government probe.
Feb 7, 2008 by Brian Orelli, PhDA Lab Match Made in HeavenThe case of Thermo Electron and Fisher Scientific shows why mergers work.
Feb 6, 2008 by Brian Orelli, PhDInsatiable IlluminaRevenue is way up, but can the company keep it going?
Feb 5, 2008 by Brian Orelli, PhDMedtronic Endeavors to CompeteMetronic joins the U.S. drug-eluting stent market.
Feb 5, 2008 by Brian Orelli, PhDBoston Scientific Gets ChargedWalloped by charges, Boston Scientific posts a loss for the quarter.
Jan 31, 2008 by Brian Orelli, PhDOne Last Look at Pre-Enhance MerckInvestors care more about the drugmaker's future than its Q4 results.
Jan 31, 2008 by Brian Orelli, PhDWyeth Calls Teva's BluffWyeth launches a generic version of its own drug.
Jan 31, 2008 by Brian Orelli, PhDInvesting Before the IPOYou can do it without a venture capital fund.
Jan 30, 2008 by Brian Orelli, PhDFoolish Fantasy Football RevisitedA look at our picks as the season winds down.
Jan 29, 2008 by Brian Orelli, PhDNo Weight Loss at AmylinBulging costs keep the drugmaker from showing a profit.
Jan 28, 2008 by Brian Orelli, PhDDr. Reddy's Rough QuarterIt moves manufacturing back to India and moves forward with OTC generic drugs.
Jan 24, 2008 by Brian Orelli, PhDAbbott Goes GlobalThe drugmaker wraps up a solid 2007 with successful expansion.
